Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 220041
Company: RICONPHARMA LLC
Company: RICONPHARMA LLC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TOPIRAMATE | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
| TOPIRAMATE | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
| TOPIRAMATE | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
| TOPIRAMATE | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
| TOPIRAMATE | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 05/26/2026 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |